AstraZeneca sues Glenmark to defend breast cancer drug

02-02-2015

AstraZeneca sues Glenmark to defend breast cancer drug

PondPond / Shutterstock.com

AstraZeneca has sued Glenmark Pharmaceuticals for allegedly infringing four patents protecting its breast cancer drug Faslodex (fulvestrant).


AstraZeneca, Glenmark, Faslodex, ANDA, US District Court for the District of New Jersey, patent

LSIPR